Literature DB >> 2527423

Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.

U E Kongsgaard1, N Smith-Erichsen, O Geiran, L Bjørnskau.   

Abstract

Components of the coagulation and fibrinolytic systems were determined in patients undergoing open heart surgery with cardiopulmonary bypass. The variables studied included prothrombin, antithrombin-III, spontaneous plasmin activity, plasminogen and functional antiplasmin activity. The variables were measured using chromogenic peptide substrate assays. A marked, transitory, increase in spontaneous plasmin activity prior to cardiopulmonary bypass, but after heparin injection was found. A decrease in antiplasmin activity during bypass was observed, while actual plasminogen level, when correcting for hemodilution, was unchanged. Both prothrombin and antithrombin-III paralleled the decrease in hemoglobin concentration during bypass. These findings suggest that the injection of heparin induced a transient activation of the fibrinolytic system, whereas no detectable consumption of the measured coagulation variables was observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527423     DOI: 10.1055/s-2007-1020309

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 2.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

3.  Clinical experience of Argatroban for anticoagulation in cardiovascular surgery.

Authors:  H Ohteki; K Furukawa; H Ohnishi; Y Narita; M Sakai; K Doi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-01

4.  Acute normovolemic hemodilution does not reduce antithrombin concentration for cardiac surgery.

Authors:  Matthew Dean Linden; Mark Schneider; Wendy Naomi Erber
Journal:  J Thromb Thrombolysis       Date:  2004-06       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.